INJ/USDT RELOADED CHART
Note - I'M publishing this chart again coz previous published chart of the same idea was hidden by moderators coz of house rule violation.
SPOT BUY CALL (BUY & HODL) buy INJECTIVE protocol (inj) in 3 parts : 1st buy - @ 2.75 , 2nd buy 20% below the first buying price ,
3rd buy 20% below from 2nd buy price
stop-loss should be placed below ma 200 which is @ $1.692. take profit zone 1ST- $3.8 -$4 take profit 2nd zone - $4 - $6.
always DO YOUR OWN RESEARCH before taking any trade or before investing your hard earned money.
Suggestion/Tip – It is always better to take profit, whether all the zones are bought or not.
Suggestion/Tip 2 - When price is moving on right way
"it is always recommended to move stop-loss to profit side".
If you like the idea and benefited from it please like , share & comment to keep us motivated.
Trade active
#INJ first target zone hit 🎯We are in 47% profit from our first entry.
Note
#INJ went up-to $4.37 , so technically it entered our tp 2 zone also. It went 59% up from our first entry. If you guys booked the profit den perfect but if not , in that case i hope you have trailed your stop-loss to the profit zone at-least.
always DO YOUR OWN RESEARCH before taking any trade or before investing your hard earned money.
Suggestion/Tip – It is always better to take profit, whether all the zones are bought or not.
Suggestion/Tip 2 - When price is moving on right way
"it is always recommended to move stop-loss to profit side".
If you like the idea and benefited from it please like , share & comment to keep us motivated.
Trade closed: target reached
Target reached fully.
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.